A T cell-based Ubiquitin-mediated mRNA Vaccine Provides Cross-Protection Against H1N1 and B Influenza Viruses in Mice
Highlights • A novel mRNA vaccine was developed to achieve broad-spectrum protection against Influenza virus. • The Ub-Re-N mRNA vaccine boosts CD8 + T cell immunity through ubiquitination modification. • Vaccinated mice had significant reduced lung damage, viral load, and cytokine levels after influenza virus challenge. • The vaccine demonstrates potential for broad-spectrum protection against H1N1 and B influenza viruses.